Report Detail
COVID-19 Impact on Global Interventional X-ray Contrast and Imaging Agents Market Insights, Forecast to 2026
- RnM3990210 |
- 05 June, 2020 |
- Global |
- 113 Pages |
- QYResearch |
- Medical Devices & Consumables
Interventional X-ray Contrast and Imaging Agents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interventional X-ray Contrast and Imaging Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Interventional X-ray Contrast and Imaging Agents market is segmented into
Iodinated Contrast Media
Barium-Based Contrast Media
Microbubble Contrast Media
Other
Segment by Application, the Interventional X-ray Contrast and Imaging Agents market is segmented into
Heart Disease
Neurological
Urology
General Surgery
Other
Regional and Country-level Analysis
The Interventional X-ray Contrast and Imaging Agents market is analysed and market size information is provided by regions (countries).
The key regions covered in the Interventional X-ray Contrast and Imaging Agents market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Interventional X-ray Contrast and Imaging Agents Market Share Analysis
Interventional X-ray Contrast and Imaging Agents market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Interventional X-ray Contrast and Imaging Agents by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Interventional X-ray Contrast and Imaging Agents business, the date to enter into the Interventional X-ray Contrast and Imaging Agents market, Interventional X-ray Contrast and Imaging Agents product introduction, recent developments, etc.
The major vendors covered:
Bracco
General Electric
Guerbet
Fujifilm Visualsonics
Imax
J.B. Chemicals & Pharmaceuticals
Jodas Expoim
Lantheus Medical Imaging
Nano Therapeutics
Novalek Pharmaceuticals
Taejoon Pharm
1 Study Coverage
- 1.1 Interventional X-ray Contrast and Imaging Agents Product Introduction
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered: Ranking of Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Revenue in 2019
- 1.4 Market by Type
- 1.4.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Type
- 1.4.2 Iodinated Contrast Media
- 1.4.3 Barium-Based Contrast Media
- 1.4.4 Microbubble Contrast Media
- 1.4.5 Other
- 1.5 Market by Application
- 1.5.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Application
- 1.5.2 Heart Disease
- 1.5.3 Neurological
- 1.5.4 Urology
- 1.5.5 General Surgery
- 1.5.6 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): Interventional X-ray Contrast and Imaging Agents Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Interventional X-ray Contrast and Imaging Agents Industry
- 1.6.1.1 Interventional X-ray Contrast and Imaging Agents Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Interventional X-ray Contrast and Imaging Agents Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Interventional X-ray Contrast and Imaging Agents Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Interventional X-ray Contrast and Imaging Agents Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Estimates and Forecasts
- 2.1.1 Global Interventional X-ray Contrast and Imaging Agents Revenue Estimates and Forecasts 2015-2026
- 2.1.2 Global Interventional X-ray Contrast and Imaging Agents Production Capacity Estimates and Forecasts 2015-2026
- 2.1.3 Global Interventional X-ray Contrast and Imaging Agents Production Estimates and Forecasts 2015-2026
- 2.2 Global Interventional X-ray Contrast and Imaging Agents Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Global Interventional X-ray Contrast and Imaging Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.3.3 Global Interventional X-ray Contrast and Imaging Agents Manufacturers Geographical Distribution
- 2.4 Key Trends for Interventional X-ray Contrast and Imaging Agents Markets & Products
- 2.5 Primary Interviews with Key Interventional X-ray Contrast and Imaging Agents Players (Opinion Leaders)
3 Market Size by Manufacturers
- 3.1 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Production Capacity
- 3.1.1 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Production Capacity (2015-2020)
- 3.1.2 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Production (2015-2020)
- 3.1.3 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers Market Share by Production
- 3.2 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Revenue
- 3.2.1 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Revenue (2015-2020)
- 3.2.2 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers Market Share by Revenue (2015-2020)
- 3.2.3 Global Top 10 and Top 5 Companies by Interventional X-ray Contrast and Imaging Agents Revenue in 2019
- 3.3 Global Interventional X-ray Contrast and Imaging Agents Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Interventional X-ray Contrast and Imaging Agents Production by Regions
- 4.1 Global Interventional X-ray Contrast and Imaging Agents Historic Market Facts & Figures by Regions
- 4.1.1 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Production (2015-2020)
- 4.1.2 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Revenue (2015-2020)
- 4.2 North America
- 4.2.1 North America Interventional X-ray Contrast and Imaging Agents Production (2015-2020)
- 4.2.2 North America Interventional X-ray Contrast and Imaging Agents Revenue (2015-2020)
- 4.2.3 Key Players in North America
- 4.2.4 North America Interventional X-ray Contrast and Imaging Agents Import & Export (2015-2020)
- 4.3 Europe
- 4.3.1 Europe Interventional X-ray Contrast and Imaging Agents Production (2015-2020)
- 4.3.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue (2015-2020)
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Interventional X-ray Contrast and Imaging Agents Import & Export (2015-2020)
- 4.4 China
- 4.4.1 China Interventional X-ray Contrast and Imaging Agents Production (2015-2020)
- 4.4.2 China Interventional X-ray Contrast and Imaging Agents Revenue (2015-2020)
- 4.4.3 Key Players in China
- 4.4.4 China Interventional X-ray Contrast and Imaging Agents Import & Export (2015-2020)
- 4.5 Japan
- 4.5.1 Japan Interventional X-ray Contrast and Imaging Agents Production (2015-2020)
- 4.5.2 Japan Interventional X-ray Contrast and Imaging Agents Revenue (2015-2020)
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Interventional X-ray Contrast and Imaging Agents Import & Export (2015-2020)
5 Interventional X-ray Contrast and Imaging Agents Consumption by Region
- 5.1 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Consumption
- 5.1.1 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Consumption (2015-2020)
- 5.1.2 Global Top Interventional X-ray Contrast and Imaging Agents Regions Market Share by Consumption (2015-2020)
- 5.2 North America
- 5.2.1 North America Interventional X-ray Contrast and Imaging Agents Consumption by Application
- 5.2.2 North America Interventional X-ray Contrast and Imaging Agents Consumption by Countries
- 5.2.3 U.S.
- 5.2.4 Canada
- 5.3 Europe
- 5.3.1 Europe Interventional X-ray Contrast and Imaging Agents Consumption by Application
- 5.3.2 Europe Interventional X-ray Contrast and Imaging Agents Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 U.K.
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption by Application
- 5.4.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption by Regions
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Taiwan
- 5.4.9 Indonesia
- 5.4.10 Thailand
- 5.4.11 Malaysia
- 5.4.12 Philippines
- 5.4.13 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Interventional X-ray Contrast and Imaging Agents Consumption by Application
- 5.5.2 Central & South America Interventional X-ray Contrast and Imaging Agents Consumption by Country
- 5.5.3 Mexico
- 5.5.3 Brazil
- 5.5.3 Argentina
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Consumption by Application
- 5.6.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 Saudi Arabia
- 5.6.5 U.A.E
6 Market Size by Type (2015-2026)
- 6.1 Global Interventional X-ray Contrast and Imaging Agents Market Size by Type (2015-2020)
- 6.1.1 Global Interventional X-ray Contrast and Imaging Agents Production by Type (2015-2020)
- 6.1.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2015-2020)
- 6.1.3 Interventional X-ray Contrast and Imaging Agents Price by Type (2015-2020)
- 6.2 Global Interventional X-ray Contrast and Imaging Agents Market Forecast by Type (2021-2026)
- 6.2.1 Global Interventional X-ray Contrast and Imaging Agents Production Forecast by Type (2021-2026)
- 6.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Forecast by Type (2021-2026)
- 6.2.3 Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Type (2021-2026)
- 6.3 Global Interventional X-ray Contrast and Imaging Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
- 7.2.1 Global Interventional X-ray Contrast and Imaging Agents Consumption Historic Breakdown by Application (2015-2020)
- 7.2.2 Global Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
- 8.1 Bracco
- 8.1.1 Bracco Corporation Information
- 8.1.2 Bracco Overview and Its Total Revenue
- 8.1.3 Bracco Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.1.4 Bracco Product Description
- 8.1.5 Bracco Recent Development
- 8.2 General Electric
- 8.2.1 General Electric Corporation Information
- 8.2.2 General Electric Overview and Its Total Revenue
- 8.2.3 General Electric Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.2.4 General Electric Product Description
- 8.2.5 General Electric Recent Development
- 8.3 Guerbet
- 8.3.1 Guerbet Corporation Information
- 8.3.2 Guerbet Overview and Its Total Revenue
- 8.3.3 Guerbet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.3.4 Guerbet Product Description
- 8.3.5 Guerbet Recent Development
- 8.4 Fujifilm Visualsonics
- 8.4.1 Fujifilm Visualsonics Corporation Information
- 8.4.2 Fujifilm Visualsonics Overview and Its Total Revenue
- 8.4.3 Fujifilm Visualsonics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.4.4 Fujifilm Visualsonics Product Description
- 8.4.5 Fujifilm Visualsonics Recent Development
- 8.5 Imax
- 8.5.1 Imax Corporation Information
- 8.5.2 Imax Overview and Its Total Revenue
- 8.5.3 Imax Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.5.4 Imax Product Description
- 8.5.5 Imax Recent Development
- 8.6 J.B. Chemicals & Pharmaceuticals
- 8.6.1 J.B. Chemicals & Pharmaceuticals Corporation Information
- 8.6.2 J.B. Chemicals & Pharmaceuticals Overview and Its Total Revenue
- 8.6.3 J.B. Chemicals & Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.6.4 J.B. Chemicals & Pharmaceuticals Product Description
- 8.6.5 J.B. Chemicals & Pharmaceuticals Recent Development
- 8.7 Jodas Expoim
- 8.7.1 Jodas Expoim Corporation Information
- 8.7.2 Jodas Expoim Overview and Its Total Revenue
- 8.7.3 Jodas Expoim Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.7.4 Jodas Expoim Product Description
- 8.7.5 Jodas Expoim Recent Development
- 8.8 Lantheus Medical Imaging
- 8.8.1 Lantheus Medical Imaging Corporation Information
- 8.8.2 Lantheus Medical Imaging Overview and Its Total Revenue
- 8.8.3 Lantheus Medical Imaging Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.8.4 Lantheus Medical Imaging Product Description
- 8.8.5 Lantheus Medical Imaging Recent Development
- 8.9 Nano Therapeutics
- 8.9.1 Nano Therapeutics Corporation Information
- 8.9.2 Nano Therapeutics Overview and Its Total Revenue
- 8.9.3 Nano Therapeutics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.9.4 Nano Therapeutics Product Description
- 8.9.5 Nano Therapeutics Recent Development
- 8.10 Novalek Pharmaceuticals
- 8.10.1 Novalek Pharmaceuticals Corporation Information
- 8.10.2 Novalek Pharmaceuticals Overview and Its Total Revenue
- 8.10.3 Novalek Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.10.4 Novalek Pharmaceuticals Product Description
- 8.10.5 Novalek Pharmaceuticals Recent Development
- 8.11 Taejoon Pharm
- 8.11.1 Taejoon Pharm Corporation Information
- 8.11.2 Taejoon Pharm Overview and Its Total Revenue
- 8.11.3 Taejoon Pharm Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.11.4 Taejoon Pharm Product Description
- 8.11.5 Taejoon Pharm Recent Development
- 8.12 Unijules Life Sciences
- 8.12.1 Unijules Life Sciences Corporation Information
- 8.12.2 Unijules Life Sciences Overview and Its Total Revenue
- 8.12.3 Unijules Life Sciences Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.12.4 Unijules Life Sciences Product Description
- 8.12.5 Unijules Life Sciences Recent Development
9 Production Forecasts by Regions
- 9.1 Global Top Interventional X-ray Contrast and Imaging Agents Regions Forecast by Revenue (2021-2026)
- 9.2 Global Top Interventional X-ray Contrast and Imaging Agents Regions Forecast by Production (2021-2026)
- 9.3 Key Interventional X-ray Contrast and Imaging Agents Production Regions Forecast
- 9.3.1 North America
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
10 Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region
- 10.1 Global Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region (2021-2026)
- 10.2 North America Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region (2021-2026)
- 10.3 Europe Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region (2021-2026)
- 10.4 Asia Pacific Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region (2021-2026)
- 10.5 Latin America Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region (2021-2026)
- 10.6 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Interventional X-ray Contrast and Imaging Agents Sales Channels
- 11.2.2 Interventional X-ray Contrast and Imaging Agents Distributors
- 11.3 Interventional X-ray Contrast and Imaging Agents Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Market Opportunities and Drivers
- 12.2 Market Challenges
- 12.3 Market Risks/Restraints
- 12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Interventional X-ray Contrast and Imaging Agents Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Interventional X-ray Contrast and Imaging Agents. Industry analysis & Market Report on COVID-19 Impact on Global Interventional X-ray Contrast and Imaging Agents is a syndicated market report, published as COVID-19 Impact on Global Interventional X-ray Contrast and Imaging Agents Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Interventional X-ray Contrast and Imaging Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
